CoChat

Cerebral Serotonin 4 Receptors and Amyloid-β in Early Alzheimer's Disease

Madsen, Karine, Neumann, Wolf-Julian, Holst, Klaus, Marner, Lisbeth, Haahr, Mette Thorlund, Lehel, Szabolcs, Knudsen, Gitte Moos, Hasselbalch, Steen Gregers · 2011 · Journal of Alzheimer’s Disease
Cited by 72

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The 5-HT 4 receptor may play a role in memory and learning and 5-HT 4 receptor activation has been suggested to modulate acetylcholine release and to reduce amyloid-β (Aβ) accumulation. The aim of this study was for the first time to investigate the in vivo cerebral 5-HT 4 receptor binding in early Alzheimer disease (AD) patients in relation to cortical Aβ burden. Eleven newly diagnosed untreated AD patients (mean MMSE 24, range 19–27) and twelve age- and gender-matched healthy controls underwent a two-hour dynamic [ 11 C]SB207145 PET scan to measure the binding potential of the 5-HT 4 receptor. All AD patients and eight healthy controls additionally underwent a [ 11 C]PIB PET scan to measure the cortical Aβ burden. When AD patients were defined on clinical criteria, no difference in cerebral 5-HT 4 receptor binding between AD patients and healthy controls was found (p = 0.54). However, when individuals were reassigned to groups according to their amyloid status, the PIB-positive individuals had 13% higher 5-HT 4 receptor levels than PIB-negative individuals (p = 0.02) and the importance of classification of groups is emphasized. The 5-HT 4 receptor binding was a positively correlated to Aβ burden (p = 0.03) and negatively to MMSE score of the AD patients (p = 0.02). Our data suggests that cerebral 5-HT 4 receptor upregulation starts at a preclinical stage of and continues while dementia is still at a mild stage, which contrasts other receptor subtypes. We speculate that this may either be a compensatory effect of decreased levels of interstitial 5-HT, an attempt to improve cognitive function, increase acetylcholine release or to counteract Aβ accumulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-2011-110056

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 72

Metadata

Authors
Madsen, K., Neumann, W.-J., Holst, K., Marner, L., Haahr, M. T., Lehel, S., Knudsen, G. M., & Hasselbalch, S. G.
Venue
Journal of Alzheimer’s Disease
Published
2011-09-19
Volume
26
Issue
3
Pages
457-466
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W137926846
Cited by
72
References
6
FWCI
3.94
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebral Serotonin 4 Receptors and Amyloid-β in Early Alzheimer's Disease. https://app.cochat.ai/papers/10.3233/jad-2011-110056
The paper
Madsen, K., Neumann, W.-J., Holst, K., Marner, L., Haahr, M. T., Lehel, S., Knudsen, G. M., & Hasselbalch, S. G. (2011). Cerebral Serotonin 4 Receptors and Amyloid-β in Early Alzheimer's Disease. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-2011-110056

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.